AG
DXCM icon

Aperio Group’s DexCom DXCM Stock Holding History

Aperio Group’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		$17.9M Sell
193,732
-34,292
-15% -$3.06M 0.05% 350
2020
Q3 		$23.5M Buy
228,024
+2,452
+1% +$256K 0.08% 242
2020
Q2 		$22.9M Buy
225,572
+37,348
+20% +$3.34M 0.08% 231
2020
Q1 		$12.7M Buy
188,224
+41,276
+28% +$2.57M 0.06% 340
2019
Q4 		$8.04M Buy
146,948
+22,484
+18% +$1.07M 0.03% 574
2019
Q3 		$4.64M Buy
124,464
+13,040
+12% +$507K 0.02% 736
2019
Q2 		$4.17M Sell
111,424
-12,796
-10% -$402K 0.02% 774
2019
Q1 		$3.7M Sell
124,220
-3,720
-3% -$131K 0.02% 794
2018
Q4 		$3.83M Buy
127,940
+20,092
+19% +$637K 0.02% 742
2018
Q3 		$3.86M Buy
107,848
+9,252
+9% +$287K 0.02% 777
2018
Q2 		$2.34M Buy
98,596
+292
+0.3% +$6.19K 0.01% 959
2018
Q1 		$1.82M Buy
98,304
+22,728
+30% +$336K 0.01% 1050
2017
Q4 		$1.08M Buy
75,576
+35,860
+90% +$466K 0.01% 1257
2017
Q3 		$486K Buy
39,716
+4,236
+12% +$74.9K ﹤0.01% 1671
2017
Q2 		$648K Buy
35,480
+5,700
+19% +$105K ﹤0.01% 1495
2017
Q1 		$631K Buy
29,780
+7,208
+32% +$141K ﹤0.01% 1420
2016
Q4 		$337K Sell
22,572
-9,396
-29% -$166K ﹤0.01% 1737
2016
Q3 		$700K Buy
31,968
+4,696
+17% +$105K 0.01% 1275
2016
Q2 		$541K Buy
27,272
+740
+3% +$12.6K ﹤0.01% 1345
2016
Q1 		$450K Buy
26,532
+13,320
+101% +$223K ﹤0.01% 1420
2015
Q4 		$271K Sell
13,212
-6,212
-32% -$129K ﹤0.01% 1676
2015
Q3 		$417K Buy
19,424
+8,804
+83% +$196K ﹤0.01% 1403
2015
Q2 		$212K Buy
+10,620
New +$187K ﹤0.01% 1828

Other funds holding DXCM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
LPC
Lone Pine Capital Greenwich, Connecticut $12.5B AUM 54.4% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Aperio Group's DXCM Position: Q4 2020 in Review

Aperio Group reduced its DexCom (DXCM) stake by 15% in Q4 2020, selling an estimated $3.06M and leaving 193,732 shares worth $17.9M. The position accounts for 0.05% of the portfolio, ranked #350.

Aperio Group first reported a position in DXCM in Q2 2015 and has held it in 23 quarters since. The position peaked at $23.5M in Q3 2020. 733 funds tracked by Wall St. Rank hold DXCM as of Q4 2020.

  • Aperio Group held 193,732 shares of DexCom worth $17.9M as of Q4 2020.
  • Aperio Group sold 34,292 DexCom shares in Q4 2020, an estimated $3.06M.
  • DexCom made up 0.05% of Aperio Group's portfolio in Q4 2020, its #350 holding.
  • Aperio Group first reported a position in DexCom in Q2 2015 and has held it in 23 quarters since.
  • Aperio Group's DexCom position peaked at $23.5M in Q3 2020.
  • 733 funds tracked by Wall St. Rank held DexCom as of Q4 2020.

Based on Aperio Group's 13F filing for Q4 2020, filed 5 Feb 2021.